CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infection

Viral Immunology

Volumn 22, Issue 2, 2009, Pages 91-103

  Cook, Charles H ^a,c   Chen, Li ^a   Wen, Jin ^a   Zimmerman, Peter ^a   Zhang, Yingxue ^a   Trgovcich, Joanne ^a   Liu, Yang ^b   Gao, Jian Xin ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c N747 Doan Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; CD86 PROTEIN, MOUSE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; IMMUNOSTIMULATION; INFECTION CONTROL; MALE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIMARY INFECTION; T LYMPHOCYTE; VIRUS LOAD; WILD TYPE; ANIMAL; BETAHERPESVIRINAE; BIOSYNTHESIS; C57BL MOUSE; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; LIVER; MOUSE MUTANT; SPLEEN; VIROLOGY;

MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1; MUS;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; CYTOKINES; HERPESVIRIDAE INFECTIONS; KILLER CELLS, NATURAL; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUROMEGALOVIRUS; SPLEEN; T-LYMPHOCYTES;

EID: 65249089586     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2008.0080     Document Type: Article

References (76)

1. Andoniou, CE, van Dommelen SL, Voigt V, et al.: Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nature Immunol 2005;6:1011-1019. (Pubitemid 41486186)
2. Andrews DM, Andoniou CE, Granucci F, Ricciardi- Castagnoli P, and Degli-Esposti MA: Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nature Immunol 2001;2:1077-1084. (Pubitemid 33069504)
3. Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, and Degli-Esposti MA: Functional interactions between dendritic cells and NK cells during viral infection. Nature Immunol 2003;4:175-181. (Pubitemid 36193020)
4. Arase H, Mocarski ES, Campbell AE, Hill AB, and Lanier LL: Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002;296:1323-1326. (Pubitemid 34522789)
5. Araullo-Cruz TP, Ho M, and Armstrong JA: Protective effect of early serum from mice after cytomegalovirus infection. Infect Immun 1978;21:840-842. (Pubitemid 9011180)
6. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, and Somoza C: B70 antigen is a second ligand for CTLA- 4 and CD28. Nature 1993;366:76-79. (Pubitemid 23345240)
7. Bancroft GJ, Shellam GR, and Chalmer JE: Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J Immunol 1981;126:988-994.
8. Bertram EM. Dawicki W, and Watts TH: Role of T cell costimulation in anti-viral immunity. Semin Immunol 2004; 16:185-196. (Pubitemid 38569899)
9. Bickerstaff AA, Zimmerman PD, Wing BA, Taylor F, Trgovcich J, and Cook CH: A flow cytometry-based method for detecting antibody responses to murine cytomegalovirus infection. J Virol Methods 2007;142:50-58. (Pubitemid 46590403)
10. Biron CA, Byron KS, and Sullivan JL: Severe herpesvirus infections in an adolescent without natural killer cells [see comment]. N Engl J Med 1989;320:1731-1735.
11. Borriello F, Sethna MP, Boyd SD, et al.: B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997;6: 303-313. (Pubitemid 27148597)
12. Bubic I, Wagner M, Krmpoti A, et al.: Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 2004;78:7536-7544. (Pubitemid 38915900)
13. Bukowski JF, Woda BA, Habu S, Okumura K, and Welsh RM: Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 1983;131: 1531-1538.
14. Bukowski JF, Woda BA, and Welsh RM: Pathogenesis of murine cytomegalovirus infection in natural killer celldepleted mice. J Virol 1984;52:119-128. (Pubitemid 14000479)
15. Butte MJ, Keir ME, Phamduy TB, Sharpe AH, and Freeman GJ: Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007;27:111-122.
16. Cavanaugh VJ, Deng Y, Birkenbach MP, Slater JS, and Campbell AE: Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. J Virol 2003;77:1703-1717. (Pubitemid 36109982)
17. Chambers BJ, Salcedo M, and Ljunggren H-G: Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 1996;5:311-317. (Pubitemid 26366754)
18. Christensen JE, Christensen JP, Kristensen NN, Hansen NJV, Stryhn A, and Thomsen AR: Role of CD28 co-stimulation in generation and maintenance of virus-specific T cells. Int Immunol 2002;14:701-711. (Pubitemid 34814630)
19. Dalod M, Hamilton T, Salomon R, Salazar-Mather TP, Henry SC, Hamilton JD, and BironCA: Dendritic cell responses to early murine cytomegalovirus infection: Subset functional specialization and differential regulation by interferon α/β. J Exp Med 2003;197:885-898. (Pubitemid 36437865)
20. Dokun AO, Chu DT, Yang L, Bendelac AS, and Yokoyama WM: Analysis of in situ NK cell responses during viral infection. J Immunol 2001;167:5286-5293. (Pubitemid 33009767)
21. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, and Yokoyama WM: Specific and nonspecific NK cell activation during virus infection. Nature Immunol 2001;2:951-956. (Pubitemid 32976168)
22. Farrell HE, and Shellam GR: Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies. J Gen Virol 1991;72:149-156.
23. Freeman GJ, Borriello F, Hodes RJ, et al.: Uncovering of functional alternative CTLA-4 counter-receptor in B7- deficient mice. Science 1993;262:907-909. (Pubitemid 24014080)
24. Freeman GJ, Gribben JG, Boussiotis V, et al.: Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993;262:909-911. (Pubitemid 24014081)
25. French AR, Sjolin H, Kim S, et al.: DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J Immunol 2006;177:4981-4990. (Pubitemid 44527567)
26. Gao J-X, Liu X, Wen J, Caligiuri MA, Stroynowski I, Zheng P, and Liu Y: Two-signal requirement for activation and effector function of natural killer cell response to allogeneic tumor cells. Blood 2003;102:4456-4463. (Pubitemid 37494110)
27. Gao J-X, Zhang H, Bai X-F, et al.: Perinatal blockade of B7-1 and B7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells. J Exp Med 2002;195:959-971. (Pubitemid 34411998)
28. Granucci F, Vizzardelli C, Pavelka N, et al.: Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2001;2:882-888. (Pubitemid 34906455)
29. Jonjic S, Pavic I, Polic B, Crnkovic I, Lucin P, and Koszinowski UH: Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 1994;179:1713-1717. (Pubitemid 24129592)
30. Klenovsek K, Weisel F, Schneider A, et al.: Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 2007;110:3472-3479. (Pubitemid 350106344)
31. Krummel MF and Allison JP: CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995;182:459-465.
32. Lawson CM, Grundy JE, and Shellam GR: Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J Gen Virol 1988;69:1987-1998.
33. Lawson CM, O'Donoghue H, and Reed WD: The role of T cells in mouse cytomegalovirus myocarditis. Immunology 1989;67:132-134. (Pubitemid 19153144)
34. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, and Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991;173:721-730.
35. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, and Ledbetter JA: CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991;174:561-569.
36. Linsley PS, Clark EA, and Ledbetter JA: T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7=BB-1. Proc Natl Acad Sci USA 1990;87:5031-5035. (Pubitemid 20224266)
37. Loewendorf A, Kruger C, Borst EM, Wagner M, Just U, and Messerle M: Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J Virol 2004;78:13062-13071. (Pubitemid 39507814)
38. Loh J, Chu DT, O'Guin AK, Yokoyama WM, and Virgin HW IV: Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol 2005;79:661-667. (Pubitemid 39648423)
39. Luque I, Reyburn H, and Strominger JL: Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells. Human Immunol 2000;61:721-728. (Pubitemid 30694636)
40. Martin-Fontecha A, Assarsson E, Carbone E, Karre K, and Ljunggren H-G: Triggering of murine NK cells by CD40 and CD86 (B7-2). J Immunol 1999;162:5910-5916. (Pubitemid 29314945)
41. Mathys S, Schroeder T, Ellwart J, Koszinowski UH, Messerle M, and Just U: Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J Infect Dis 2003;187:988-999. (Pubitemid 36337912)
42. Mintern JD, Klemm EJ, Wagner M, et al.: Viral interference with B7-1 costimulation: A new role for murine cytomegalovirus Fc receptor-1. J Immunol 2006;177:8422-8431. (Pubitemid 44893804)
43. Low targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 2003; 19:561-569.
44. Müller A, Schmitt L, Raftery M, and Schönrich G: Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechanism of local tolerance induction. Eur J Immunol 1998;28:3488-3498.
45. Nandi D, Gross JA, and Allison JP: CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J Immunol 1994;152:3361-3369. (Pubitemid 24098032)
46. Nguyen KB, Salazar-Mather TP, Dalod MY, et al.: Coordinated and distinct roles for IFN-α/β, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002;169:4279-4287.
47. Orange J, and Biron C: An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 1996; 156:1138-1142. (Pubitemid 26048109)
48. Pahl-Seibert M-F, Juelch M, Podlech J, Thomas D, Deegen P, Reddehase MJ, and Holtappels R: Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting. J Virol 2005;79:5400-5413. (Pubitemid 40548208)
49. Pardigon N, Bercovici N, Calbo S, Santos-Lima EC, Liblau R, Kourilsky P, and Abastado JP: Role of co-stimulation in CD8+T cell activation. Int Immunol 1998;10:619-630. (Pubitemid 28221463)
50. Podlech J, Holtappels R, Pahl-Seibert MF, Steffens HP, and Reddehase MJ: Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 2000;74:7496-7507. (Pubitemid 30613095)
51. Quinnan GV, and Manischewitz JE: The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J Exp Med 1979; 150:1549-1554.
52. Quinnan GV, Manischewitz JE, and Ennis FA: Cytotoxic T lymphocyte response to murine cytomegalovirus infection. Nature 1978;273:541-543. (Pubitemid 8346585)
53. Quinnan GV, Manischewitz JE, and Ennis PA: Role of cytotoxic T lymphocytes in murine cytomegalovirus infection. J Gen Virol 1980;47:503-508. (Pubitemid 10092484)
54. Reddehase MJ, Keil GM, and Koszinowski UH: The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage-specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors. Eur J Immunol 1984;14:56-61.
55. Reddehase MJ, Mutter W, Munch K, Buhring HJ, and Koszinowski UH: CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 1987;61:3102-3108.
56. Reddehase MJ, Weiland F, Munch K, Jonjic S, Luske A, and Koszinowski UH: Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 1985;55:264-273. (Pubitemid 16239710)
57. Robbins SH, Bessou G, Cornillon A, et al.: Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathogens 2007;3:e123.
58. Robbins SH, Tessmer MS, Mikayama T, and Brossay L: Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J Immunol 2004;173:259-266. (Pubitemid 38797350)
59. Schwartz RH: Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7=BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:1065-1068.
60. Shahinian A, Pfeffer K, Lee KP, et al.: Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993;261:609-612. (Pubitemid 23278372)
61. Shanley JD, Jordan MC, and Stevens JG: Modification by adoptive humoral immunity of murine cytomegalovirus infection. J Infect Dis 1981;143:231-237.
62. Shellam GR, Allan JE, Papadimitriou JM, and Bancroft GJ: Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci USA 1981;78:5104-5108. (Pubitemid 12229681)
63. Simmons RL, Matas AJ, Rattazzi LC, Balfour HH Jr, Howard JR, and Najarian JS: Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery 1977;82:537-546. (Pubitemid 8226480)
64. Smith HRC, Heusel JW, Mehta IK, et al.: Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002;99:8826-8831. (Pubitemid 34693643)
65. Spector SA, Wong R, Hsia K, Pilcher M, and Stempien MJ: Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J Clin Invest 1998; 101:497-502. (Pubitemid 28067348)
66. Starr SE, and Allison AC: Role of T lymphocytes in recovery from murine cytomegalovirus infection. Infect Immun 1977; 17:458-462. (Pubitemid 8161003)
67. Sylwester AW, Mitchell BL, Edgar JB, et al.: Broadly targeted human cytomegalovirus-specific CD4+ and CD8+T cells dominate the memory compartments of exposed subjects. J Exp Med 2005;202:673-685.
68. Tay C, and Welsh R: Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 1997;71:267-275. (Pubitemid 26412288)
69. Tay CH, Yu LYY, Kumar V, Mason L, Ortaldo JR, and Welsh RM: The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. J Immunol 1999;162:718-726. (Pubitemid 29035392)
70. Thebeau LG, and Morrison LA: B7 costimulation plays an important role in protection from herpes simplex virus type 2-mediated pathology. J Virol 2002;76:2563-2566.
71. Thebeau LG, Vagvala SP, Wong YM, and Morrison LA: B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient mice. J Virol 2007;81:12200-12209.
72. Tripathy SK, Smith HRC, Holroyd EA, Pingel JT, and Yokoyama WM: Expression of m157, a murine cytomegalovirus- encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I. J Virol 2006;80:545-550.
73. Voigt V, Forbes CA, Tonkin JN, Degli-Esposti MA, Smith HRC, Yokoyama WM, and Scalzo AA: Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci USA 2003; 100:13483-13488. (Pubitemid 37444768)
74. Waisman A, Croxford AL, and Demircik F: New tools to study the role of B cells in cytomegalovirus infections. Med Microbiol Immunol 2008;197:145-149.
75. Wilson JL, Charo J, Martin-Fontecha A, et al.: NK cell triggering by the human costimulatory molecules CD80 and CD86. J Immunol 1999;163:4207-4212. (Pubitemid 29474484)
76. Wu Y, Guo Y, Huang A, Zheng P, and Liu Y: CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J Exp Med 1997;185:1327-1336. (Pubitemid 27172913)